IBDEI0CY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5814,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,5814,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,5814,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,5815,0)
 ;;=592.0^^28^385^2
 ;;^UTILITY(U,$J,358.3,5815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5815,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,5815,1,4,0)
 ;;=4^CALCULUS OF KIDNEY
 ;;^UTILITY(U,$J,358.3,5815,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,5816,0)
 ;;=592.1^^28^385^3
 ;;^UTILITY(U,$J,358.3,5816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5816,1,3,0)
 ;;=3^592.1
 ;;^UTILITY(U,$J,358.3,5816,1,4,0)
 ;;=4^CALCULUS OF URETER
 ;;^UTILITY(U,$J,358.3,5816,2)
 ;;=^124125
 ;;^UTILITY(U,$J,358.3,5817,0)
 ;;=591.^^28^385^4
 ;;^UTILITY(U,$J,358.3,5817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5817,1,3,0)
 ;;=3^591.
 ;;^UTILITY(U,$J,358.3,5817,1,4,0)
 ;;=4^HYDRONEPHROSIS
 ;;^UTILITY(U,$J,358.3,5817,2)
 ;;=^59672
 ;;^UTILITY(U,$J,358.3,5818,0)
 ;;=344.61^^28^385^5
 ;;^UTILITY(U,$J,358.3,5818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5818,1,3,0)
 ;;=3^344.61
 ;;^UTILITY(U,$J,358.3,5818,1,4,0)
 ;;=4^NEUROGENIC BLADDER
 ;;^UTILITY(U,$J,358.3,5818,2)
 ;;=^20561
 ;;^UTILITY(U,$J,358.3,5819,0)
 ;;=753.20^^28^385^6
 ;;^UTILITY(U,$J,358.3,5819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5819,1,3,0)
 ;;=3^753.20
 ;;^UTILITY(U,$J,358.3,5819,1,4,0)
 ;;=4^UNSP OBS DEF/RENAL PEL&URET
 ;;^UTILITY(U,$J,358.3,5819,2)
 ;;=^272985
 ;;^UTILITY(U,$J,358.3,5820,0)
 ;;=599.60^^28^385^8
 ;;^UTILITY(U,$J,358.3,5820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5820,1,3,0)
 ;;=3^599.60
 ;;^UTILITY(U,$J,358.3,5820,1,4,0)
 ;;=4^URINARY OBSTRUCTION NOS
 ;;^UTILITY(U,$J,358.3,5820,2)
 ;;=^332849
 ;;^UTILITY(U,$J,358.3,5821,0)
 ;;=599.69^^28^385^7
 ;;^UTILITY(U,$J,358.3,5821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5821,1,3,0)
 ;;=3^599.69
 ;;^UTILITY(U,$J,358.3,5821,1,4,0)
 ;;=4^URINARY OBSTRUCTION NEC
 ;;^UTILITY(U,$J,358.3,5821,2)
 ;;=^332813
 ;;^UTILITY(U,$J,358.3,5822,0)
 ;;=150.9^^28^386^6
 ;;^UTILITY(U,$J,358.3,5822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5822,1,3,0)
 ;;=3^150.9
 ;;^UTILITY(U,$J,358.3,5822,1,4,0)
 ;;=4^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,5822,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,5823,0)
 ;;=154.0^^28^386^5
 ;;^UTILITY(U,$J,358.3,5823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5823,1,3,0)
 ;;=3^154.0
 ;;^UTILITY(U,$J,358.3,5823,1,4,0)
 ;;=4^COLON CANCER
 ;;^UTILITY(U,$J,358.3,5823,2)
 ;;=^267089
 ;;^UTILITY(U,$J,358.3,5824,0)
 ;;=155.0^^28^386^10
 ;;^UTILITY(U,$J,358.3,5824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5824,1,3,0)
 ;;=3^155.0
 ;;^UTILITY(U,$J,358.3,5824,1,4,0)
 ;;=4^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,5824,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,5825,0)
 ;;=157.9^^28^386^17
 ;;^UTILITY(U,$J,358.3,5825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5825,1,3,0)
 ;;=3^157.9
 ;;^UTILITY(U,$J,358.3,5825,1,4,0)
 ;;=4^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,5825,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,5826,0)
 ;;=162.9^^28^386^11
 ;;^UTILITY(U,$J,358.3,5826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5826,1,3,0)
 ;;=3^162.9
 ;;^UTILITY(U,$J,358.3,5826,1,4,0)
 ;;=4^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,5826,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,5827,0)
 ;;=170.9^^28^386^2
 ;;^UTILITY(U,$J,358.3,5827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5827,1,3,0)
 ;;=3^170.9
 ;;^UTILITY(U,$J,358.3,5827,1,4,0)
 ;;=4^BONE CANCER
 ;;^UTILITY(U,$J,358.3,5827,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,5828,0)
 ;;=172.9^^28^386^14
 ;;^UTILITY(U,$J,358.3,5828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5828,1,3,0)
 ;;=3^172.9
 ;;^UTILITY(U,$J,358.3,5828,1,4,0)
 ;;=4^MELANOMA
 ;;
 ;;$END ROU IBDEI0CY
